Consylman Gina 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Consylman Gina
Chief Accounting Officer
Transactions
- Sale
Class A Common Stock
2021-02-26$9.11/sh−2,527$23,021→ 349,466 total - Sale
Class A Common Stock
2021-02-26$9.11/sh−6,242$56,865→ 343,224 total - Sale
Class A Common Stock
2021-02-26$9.11/sh−2,657$24,205→ 351,993 total - Sale
Class A Common Stock
2021-02-26$9.11/sh−6,980$63,588→ 336,244 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2017.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 21, 2018.
- [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.
- [F4]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020.